Exosomes derived from mesenchymal stem cells primed with disease-condition-serum improved therapeutic efficacy in a mouse rheumatoid arthritis model via enhanced TGF-β1 production
Eun Wha Choi(Kangwon National University), Sungjoo Kim(Samsung Medical Center)
Cited by 27
Related Papers
CKD-506, a novel HDAC6-selective inhibitor, improves renal outcomes and survival in a mouse model of systemic lupus erythematosus
|Scientific Reports|2018|60
Therapeutic effects of anti-CD154 antibody in cynomolgus monkeys with advanced rheumatoid arthritis
|Scientific Reports|2018|14